1Q11 Company Financials: Orthopaedic and Spine

• Posted in Business Critical | August 31, 2011 | Comments (0)
• Tags: supplier, vetalice, earnings, spine, device company, financial, market growth, orthopaedic, company financials, sales, oem, earning
• By: Julie A. Vetalice

Here we present available company earnings for 1Q11. Our estimates place overall market growth at 4% over 1Q10, as seen in Exhibit 1, which displays 1Q orthopaedic sales growth by product segment for select companies. Performance highlights follow. Highlights pertain to 1Q11 unless otherwise noted.

Exhibit 1: Orthopaedic Sales¹ Increases by Product Segment: 1Q11 vs. 1Q10

Notes to Exhibit 1

¹Orthopaedic products only; constant currency, pro forma growth
²Includes biologics
³For the quarter ended 2/28/11; trauma includes stimulators; spine includes stimulators and orthobiologics.
⁴For the quarter ended 4/29/11
⁵Spine
⁶For the quarter ended 3/31/11
⁷Extremities: Extremities + Fixation combined; Endoscopy: Endoscopic + Communications, mostly orthopaedic; Spine: Neuro + Spine. Total growth excludes Patient Handling.
⁸ORTHOWORLD estimates
⁹Excludes Other (Aerospace)